The burgeoning landscape of novel treatments for metabolic management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a https://hassanlpeo622766.illawiki.com/2044498/retatrutide_vs_tirzepatide_a_comparative_analysis